Buscas alternativas:
release processes » decrease processes (Expandir a busca), related processes (Expandir a busca), disease processes (Expandir a busca)
decrease release » decreases disease (Expandir a busca), decrease renal (Expandir a busca), protease release (Expandir a busca)
decreased ligand » decreased and (Expandir a busca), decreased in (Expandir a busca), decreases and (Expandir a busca)
ligand decrease » and decrease (Expandir a busca), ligand release (Expandir a busca), ligands increased (Expandir a busca)
decrease toc » decrease of (Expandir a busca), decrease the (Expandir a busca), decreased to (Expandir a busca)
toc decrease » to decrease (Expandir a busca), the decrease (Expandir a busca), not decrease (Expandir a busca)
in decreased » is decreased (Expandir a busca), in deceased (Expandir a busca), and decreased (Expandir a busca)
release processes » decrease processes (Expandir a busca), related processes (Expandir a busca), disease processes (Expandir a busca)
decrease release » decreases disease (Expandir a busca), decrease renal (Expandir a busca), protease release (Expandir a busca)
decreased ligand » decreased and (Expandir a busca), decreased in (Expandir a busca), decreases and (Expandir a busca)
ligand decrease » and decrease (Expandir a busca), ligand release (Expandir a busca), ligands increased (Expandir a busca)
decrease toc » decrease of (Expandir a busca), decrease the (Expandir a busca), decreased to (Expandir a busca)
toc decrease » to decrease (Expandir a busca), the decrease (Expandir a busca), not decrease (Expandir a busca)
in decreased » is decreased (Expandir a busca), in deceased (Expandir a busca), and decreased (Expandir a busca)
1
“... oligodeoxynucleotide (CpG ODNs), and CD40 ligand (CD40L) can decrease ligature-induced periodontal inflammation and...”
Acessar documento
Acessar documento
Artigo
2
“... oligodeoxynucleotide (CpG ODNs), and CD40 ligand (CD40L) can decrease ligature-induced periodontal inflammation and...”
Acessar documento
Acessar documento
Artigo
3
“... histopathological processes such as neutrophil infiltration, changes in cytoarchitecture, and necrosis...”
Acessar documento
Acessar documento
Artigo
4
“... receptor activator of NF-κB ligand (RANKL)/receptor activator of NF-κB (RANK)/osteoprotegerin (OPG) pathway...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Artigo
5
“...-inducing ligand (TRAIL) were detected by ELISA. High mobility group box 1 (HMGB1) was determined by qPCR...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Artigo
6
8
9
10
11
12
14
16
“... analyses and immunostaining of osteoprotegerin (OPG), receptor activator of nuclear kappa B ligand (RANKL...”
Acessar documento
Acessar documento
Artigo
17
“... analyses and immunostaining of osteoprotegerin (OPG), receptor activator of nuclear kappa B ligand (RANKL...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Artigo
18
“.... Short-term exposure to elevated PCO2 decreased olfactory sensitivity to some odorants, such as L-serine...”
Acessar documento
Acessar documento
Artigo
19
“... receptor activator of nuclear factor kappa-B ligand (RANKL). The rats that performed ST (ST-Veh) or were...”
Acessar documento (1)
Acessar documento (2)
Acessar documento (1)
Acessar documento (2)
Artigo
20